Ipratropium bromide
Top View
- Newer Therapies in COPD
- Ipratropium Bromide Solution Cobalt Laboratories, Inc.
- Ipratropium Bromide
- CDR Pharmacoeconomic Review Report for Trelegy Ellipta
- 209482Orig1s000
- Stembook 2018.Pdf
- Patient's Instructions for Use Ipratropium Bromide Inhalation
- Use of Inhaled Anticholinergic Agents in Obstructive Airway Disease Ruben D Restrepo MD RRT
- Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
- Anticholinergic Syndrome 23 William J
- CDPHP Medicaid Select/HARP Clinical Formulary 2021
- Bretaris Genuair, INN-Aclidinium Bromide
- Inhaled Beta-Agonist Combination Agents
- Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme
- Role of Ipratropium Bromide and Tiotropium in Chronic Obstructive Pulmonary Disease
- Prior Authorization PDL Implementation Schedule
- Intranasal Rhinitis Agents Review 05/07/2008
- Chronic Obstructive Pulmonary Disease (“COPD”) Medication Guide